205 related articles for article (PubMed ID: 22108448)
1. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
[TBL] [Abstract][Full Text] [Related]
2. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.
Pajunen P; Kotronen A; Korpi-Hyövälti E; Keinänen-Kiukaanniemi S; Oksa H; Niskanen L; Saaristo T; Saltevo JT; Sundvall J; Vanhala M; Uusitupa M; Peltonen M
BMC Public Health; 2011 Oct; 11():754. PubMed ID: 21962038
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?
Fu JF; Shi HB; Liu LR; Jiang P; Liang L; Wang CL; Liu XY
World J Gastroenterol; 2011 Feb; 17(6):735-42. PubMed ID: 21390143
[TBL] [Abstract][Full Text] [Related]
5. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.
Barchetta I; Angelico F; Del Ben M; Baroni MG; Pozzilli P; Morini S; Cavallo MG
BMC Med; 2011 Jul; 9():85. PubMed ID: 21749681
[TBL] [Abstract][Full Text] [Related]
6. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people.
Sung KC; Wild SH; Kwag HJ; Byrne CD
Diabetes Care; 2012 Nov; 35(11):2359-64. PubMed ID: 22829522
[TBL] [Abstract][Full Text] [Related]
7. Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
Kim D; Kim W; Kwak MS; Chung GE; Yim JY; Ahmed A
PLoS One; 2017; 12(10):e0186702. PubMed ID: 29049354
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults.
Karnikowski M; Córdova C; Oliveira RJ; Karnikowski MG; Nóbrega Ode T
Sao Paulo Med J; 2007 Nov; 125(6):333-7. PubMed ID: 18317603
[TBL] [Abstract][Full Text] [Related]
9. Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma.
Basyigit S; Uzman M; Kefeli A; Sapmaz FP; Yeniova AO; Nazligul Y; Asiltürk Z
Int J Clin Exp Med; 2015; 8(10):18601-10. PubMed ID: 26770473
[TBL] [Abstract][Full Text] [Related]
10. Association of high sensitivity C-reactive protein with the components of metabolic syndrome in diabetic and non-diabetic individuals.
Sigdel M; Kumar A; Gyawali P; Shrestha R; Tuladhar ET; Jha B
J Clin Diagn Res; 2014 Jun; 8(6):CC11-3. PubMed ID: 25120975
[TBL] [Abstract][Full Text] [Related]
11. PFHxS Exposure and the Risk of Non-Alcoholic Fatty Liver Disease.
Ulhaq ZS; Tse WKF
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254982
[TBL] [Abstract][Full Text] [Related]
12. Relationship between METS-IR and thyroid cancer incidence in Korea: a nationwide population-based study.
Kim HR; Son M; Huh SJ; Moon SY; Moon H; Kang YW; Koh M; Lee JY
Front Oncol; 2024; 14():1383864. PubMed ID: 38665956
[TBL] [Abstract][Full Text] [Related]
13. The Combined Effect of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome on Osteoporosis in Postmenopausal Females in Eastern China.
Chen DZ; Xu QM; Wu XX; Cai C; Zhang LJ; Shi KQ; Shi HY; Li LJ
Int J Endocrinol; 2018; 2018():2314769. PubMed ID: 30151008
[TBL] [Abstract][Full Text] [Related]
14. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
Wei JL; Leung JC; Loong TC; Wong GL; Yeung DK; Chan RS; Chan HL; Chim AM; Woo J; Chu WC; Wong VW
Am J Gastroenterol; 2015 Sep; 110(9):1306-14; quiz 1315. PubMed ID: 26215532
[TBL] [Abstract][Full Text] [Related]
16. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors.
Jin YJ; Kim KM; Hwang S; Lee SG; Ha TY; Song GW; Jung DH; Kim KH; Yu E; Shim JH; Lim YS; Lee HC; Chung YH; Lee Y; Suh DJ
J Gastroenterol Hepatol; 2012 Aug; 27(8):1341-7. PubMed ID: 22554085
[TBL] [Abstract][Full Text] [Related]
17. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects.
Kim NH; Kim JH; Kim YJ; Yoo HJ; Kim HY; Seo JA; Kim NH; Choi KM; Baik SH; Choi DS; Kim SG
Liver Int; 2014 Apr; 34(4):604-11. PubMed ID: 24382309
[TBL] [Abstract][Full Text] [Related]
18. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
19. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Younossi Z; Anstee QM; Marietti M; Hardy T; Henry L; Eslam M; George J; Bugianesi E
Nat Rev Gastroenterol Hepatol; 2018 Jan; 15(1):11-20. PubMed ID: 28930295
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
